Vir Biotechnology, Inc. - Common Stock (VIR)
10.51
+0.20 (1.94%)
Vir Biotechnology Inc. is a biotechnology company focused on leveraging the immune system to develop transformative therapies for infectious diseases and other serious conditions
It aims to create innovative treatments that harness the power of antibodies and other immune-based technologies to target a variety of diseases, including viral infections and immune-related disorders. Through its cutting-edge research and development efforts, the company seeks to improve health outcomes and provide novel solutions to unmet medical needs, with a particular emphasis on addressing global health challenges.
Frequently Asked Questions
Is Vir Biotechnology, Inc. - Common Stock publicly traded?
Yes, Vir Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Vir Biotechnology, Inc. - Common Stock trade on?
Vir Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vir Biotechnology, Inc. - Common Stock?
The ticker symbol for Vir Biotechnology, Inc. - Common Stock is VIR on the Nasdaq Stock Market
What is the current price of Vir Biotechnology, Inc. - Common Stock?
The current price of Vir Biotechnology, Inc. - Common Stock is 10.51
When was Vir Biotechnology, Inc. - Common Stock last traded?
The last trade of Vir Biotechnology, Inc. - Common Stock was at 12:40 pm EST on January 31st, 2025
What is the market capitalization of Vir Biotechnology, Inc. - Common Stock?
The market capitalization of Vir Biotechnology, Inc. - Common Stock is 1.41B
How many shares of Vir Biotechnology, Inc. - Common Stock are outstanding?
Vir Biotechnology, Inc. - Common Stock has 133.98M shares outstanding.